Appendix A
Workshop Agenda

Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Drug Development


July 22, 2010


The Keck Center, Room 100

500 Fifth Street, N.W.

Washington, DC 20001

MEETING OBJECTIVE

To explore relevant issues related to developing a cultural, legal, and behavioral framework of collaboration that enables biospecimen and data sharing.

  • What are the critical factors necessary for a successful collaboration?

  • What lessons can be learned from existing collaborations?

  • What are the challenges that exist and potential ways to overcome them?

8:00-9:00 A.M.

WORKING BREAKFAST

9:00 A.M.

PUBLIC WORKSHOP BEGINS

9:00-9:10 A.M.

Welcome and Introductory Remarks

 

Geoffrey Ginsburg, Director, Center for Genomic Medicine, Institute for Genomic Sciences & Policy, Duke University



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 57
Appendix A Workshop Agenda Establishing Precompetitive Collaborations to Stimulate Genomics- Driven Drug Development July 22, 2010 The keck Center, Room 100 500 Fifth Street, N.W. Washington, DC 20001 MEETING ObJECTIvE To explore relevant issues related to developing a cultural, legal, and behavioral framework of collaboration that enables biospecimen and data sharing. · hat are the critical factors necessary for a successful W collaboration? · What lessons can be learned from existing collaborations? · hat are the challenges that exist and potential ways to overcome W them? 8:00-9:00 A.M. WORkING bREAkFAST 9:00 A.M. PubLIC WORkSHOP bEGINS Welcome and Introductory Remarks 9:00-9:10 A.M. Geoffrey Ginsburg, Director, Center for Genomic Medicine, Institute for Genomic Sciences & Policy, Duke University 57

OCR for page 57
58 ESTABLISHING PRECOMPETITIVE COLLABORATIONS 9:10-9:55 A.M. ExTENDING THE SPECTRuM OF PRECOMPETITIvE ONCOLOGy bIOMEDICAL RESEARCH: A SuMMARy Moderator: Martha Turner, American Nurses Association Lessons Learned 9:10-9:35 A.M. Stephen Friend, President and Chief Executive Officer (CEO), Sage Bionetworks Discussion 9:35-9:55 A.M. 9:55-11:30 A.M. REQuISITES FOR SuCCESSFuL PRECOMPETITIvE COLLAbORATION Moderator: Sharon Terry, Genetic Alliance The Architecture of Collaboration 9:55-10:15 A.M. William J. Spencer, Chairman Emeritus, SEMATECH Requisites from the Pharmaceutical Industry 10:15-10:35 A.M. Aidan Power, Vice President and Global Head of Molecular Medicine, Pfizer Inc. 10:35-10:50 A.M. bREAk Requisites from Diagnostic Companies 10:50-11:10 A.M. Marcia Eisenberg, Senior Vice President, LabCorp Requisites from Academia 11:10-11:30 A.M. Neal Cohen, Vice Dean, School of Medicine, Professor of Anesthesia and Perioperative Care and Medicine, Director of International Medical Services, University of California, San Francisco WORkING LuNCH 11:30 A.M.- 12:30 P.M.

OCR for page 57
59 APPENDIX A 12:30-2:05 P.M. FRAMEWORk OF COLLAbORATIONS WITH THE PHARMACEuTICAL INDuSTRy Moderator: Aidan Power, Pfizer Inc. Public–Private Partnerships with NIH or 12:30-12:50 P.M. Government Thomas Insel, Director of the National Institute of Mental Health, National Institutes of Health Advancing Technological Achievements Through 12:50-1:10 P.M. Collaboration Christopher Beecher, Research Professor, Michigan Center for Translational Pathology, University of Michigan Open Access Partnerships 1:10-1:30 P.M. Aled Edwards, Director and CEO, Structural Genomics Consortium; Professor, Department of Medical Biophysics, University of Toronto Access to Large-Scale Data Networks 1:30-1:50 P.M. Stephen Friend, President and CEO, Sage Bionetworks 1:50-2:05 P.M. bREAk 2:05-4:05 P.M. bIOSPECIMENS Moderator: Geoffrey Ginsburg, Duke University Sustaining Access to biospecimens 2:05-2:25 P.M. Martin Yuille, Reader in Biobanking, Co-director, Centre for Integrated Genomic Medical Research, University of Manchester Developing Common biorepository Infrastructures 2:25-2:45 P.M. Carolyn Compton, Director, Office of Biorepositories and Biospecimen Research, National Cancer Institute

OCR for page 57
60 ESTABLISHING PRECOMPETITIVE COLLABORATIONS Linking Health Outcomes Data to biorepository 2:45-3:05 P.M. Samples Cynthia Helphingstine, President and CEO, Fairbanks Institute for Healthy Communities Creating a National virtual biospecimen bank 3:05-3:25 P.M. Lorraine Q. Frazier, Nancy B. Willerson Distinguished Professorship, Assistant Dean & Department Chair, Nursing Systems, Professor, Department of Nursing Systems, University of Texas Health Science Center at Houston Opportunities and Challenges of Clinical and 3:25-3:45 P.M. Genetic Data Access in the Pharmaceutical Industry Sally John, Head of Human Genetics, Molecular Medicine, PharmaTherapeutics Research, Pfizer Inc. Ethical Challenges for biospecimen and Data 3:45-4:05 P.M. Sharing Ellen Wright Clayton, Rosalind E. Franklin Professor of Genetics and Health Policy; Director, Center for Biomedical Ethics and Society, Vanderbilt University 4:05-5:05 P.M. PANEL DISCuSSION Developing a cultural, legal, and behavioral 4:05 - 5:05 P.M. framework of collaboration that enables resource sharing in order to accelerate genomics-based drug and diagnostic product development Moderator: Stephen Eck, Eli Lilly and Company Panelists: Ellen Wright Clayton, Rosalind E. Franklin Professor of Genetics and Health Policy; Director, Center for Biomedical Ethics and Society, Vanderbilt University

OCR for page 57
61 APPENDIX A Kelly Edwards, Associate Professor, Department of Bioethics and Humanities, University of Washington School of Medicine Lorraine Q. Frazier, Nancy B. Willerson Distinguished Professorship, Assistant Dean & Department Chair, Nursing Systems, Professor, Department of Nursing Systems, University of Texas Health Science Center at Houston Geoffrey Ginsburg, Director, Center for Genomic Medicine, Institute for Genomic Sciences & Policy, Duke University Garry Neil, Corporate Vice President, COSAT, Johnson & Johnson William J. Spencer, Chairman Emeritus, SEMATECH Sharon Terry, President and CEO, Genetic Alliance 5:05-5:30 P.M. SuMMARy AND CONCLuSIONS Geoffrey Ginsburg, Director, Center for Genomic Medicine, Institute for Genomic Sciences & Policy, Duke University Stephen Eck, Vice President, Translational Medicine & Pharmacogenomics, Eli Lilly and Company Aidan Power, Vice President and Global Head of Molecular Medicine, Pfizer Inc. Sharon Terry, President and CEO, Genetic Alliance

OCR for page 57